Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study-Reference-Cited by-同舟云学术

Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study

Published:2024-06-07 Issue: Volume: Page:1-10
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Fierens Liselotte¹,Coenen Sofie²,Joly Johan³,Vanhoutvin Tine⁴,De Dycker Els⁵,Bertrand Delphine³⁶,Van Laer Eva⁷,Penny Jens⁸,Reumers Jan⁸,Verschueren Patrick³⁶,De Haes Petra⁴⁹,De Munter Paul⁹¹⁰,Ferrante Marc¹⁵

Affiliation:

1. Department of Chronic and Metabolic diseases, KU Leuven, Leuven, Belgium

2. Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium

3. Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium

4. Department of Dermatology, University Hospitals Leuven, Leuven, Belgium

5. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium

6. Department of Development and Regeneration, KU Leuven, Leuven, Belgium

7. Hospital Pharmacy, University Hospitals Leuven, Leuven, Belgium

8. Department of Information Systems – IT, University Hospitals Leuven, Leuven, Belgium

9. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

10. Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium

Funder

Pfizer

Pfizer Inc.

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2024.2361795

Reference25 articles.

1. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

2. The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions

3. New biologics and small molecules in inflammatory bowel disease: an update

4. New biologics and oral drugs in treatment of moderate to severe psoriasis;Naidu H;J Drugs Dermatol,2022

5. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment